FDA IMPORT REQUIREMENTS AND BEST PRACTICES FOR …
FDA IMPORT REQUIREMENTS AND BEST PRACTICES FOR
DRUGS AND MEDICAL DEVICES
September 2015
FDA Import Requirements and Best Practices for Drugs and
Medical Devices
FDA Import Requirements and Best Practices for Drugs and Medical Devices
Table of Contents
1. Introduction and Abbreviation Table ..................................................................................................3 2. Importation Process Diagram ............................................................................................................6 3. PREDICT...........................................................................................................................................6 4. MARCS
a. Data Transmission Requirements .......................................................................................8 b. FDA Establishment Registration........................................................................................12 5. OASIS..............................................................................................................................................12 6. Import Trade Auxiliary Communications System (ITACS) ...............................................................13 7. Drugs a. What is a drug? .................................................................................................................14 b. What is an unapproved drug? ...........................................................................................14 c. Drug Development & Steps Toward Drug Approval ..........................................................14 d. API Importation..................................................................................................................15 e. Drug Listing .......................................................................................................................18 f. Drug Labeling for Importation ............................................................................................21 g. R&D Human Use/Investigational Samples ........................................................................22 h. R&D Non-Human Use (Unapproved) ................................................................................24 i. Non-human Use (Approved and Unapproved) ................................................................. 25 8. Devices............................................................................................................................................26 9. Vaccines and Biologics ? CBER Products.......................................................................................31 10. FDA Review Statuses & Responding to FDA Detention a. FDA Review Statuses........................................................................................................32 b. Responding to FDA Detention...........................................................................................33 11. Import Alerts ....................................................................................................................................35 12. Special Situations a. Import for Export................................................................................................................36 b. PLAIR ................................................................................................................................38 c. Foreign Trade Zone...........................................................................................................40 d. Returned of U.S. Pharma ..................................................................................................41 e. Prior Notice........................................................................................................................42 13. Appendix a. Constructing the Manufacturer Code.................................................................................44 b. FDA Product Code Builder ................................................................................................46 c. FDA's Integration to the Automated Commercial Environment (ACE)/International Trade
Data Systems (ITDS).........................................................................................................49 d. Violation Code Translations...............................................................................................53 e. Website Links ....................................................................................................................54
- 2 -
FDA Import Requirements and Best Practices for Drugs and Medical Devices
1a. Introduction
A cross-functional team from branded and generic pharmaceutical and medical device companies prepared this manual in order to assist the U.S. importer of FDA regulated merchandise. Compliance to the FDA's import regulations and processes continues to be a core competency for U.S. importers as supply chains expand and become more complex. This manual should be utilized as one of many tools in an importer's tool box for compliance with U.S. Participating Government Agencies with import jurisdiction.
This manual serves as a reference source and not meant to provide any legal or regulatory advice. Please note that the abbreviation FD&C Act refers to the Food, Drug & Cosmetic Act.
1b. Abbreviation table
ABI ACE ACC ACS AofC ANC ANDA API BLA
Automated Broker Interface (with CBP) Automated Commercial Environment Accession Number Automated Commercial System (CBP) Affirmation of Compliance codes (for FDA) Annual Report Accession Number Abbreviated New Drug Application Active Pharmaceutical Ingredient Biologics License Application
CBER CBP CDER CFR CM CMC CPT DEV DII DIOP
Center for Biologics Evaluation and Research Customs & Border Protection Center for Drug Evaluation and Research Code of Federal Regulations Contract Manufacturer Chemical Manufacturing Control Component of Device Foreign Manufacturer Registration Number Initial Importer Registration Number Division of Import Operations and Policy (FDA)
DLS
Drug Listing number
- 3 -
FDA Import Requirements and Best Practices for Drugs and Medical Devices
DUNS FDA FD&C Act FEI FP FTZ HDE HPUS IDE IFE IND ISO ITACS LST MARCS MID NDA NDC NF OASIS ORA OTC PDP PLAIR PLD PMA PMN
Data Universal Numbering System; Dun and Bradstreet Food and Drug Administration Federal Food, Drug, & Cosmetic Act (FDA) Facility Establishment Identifier number (FDA) Finished Product Foreign Trade Zone (US CBP Regulated) Humanitarian Device Exemption Homeopathic Pharmacopoeia of the United States Investigational Device Exemption Import For Export (FDA) Investigational New Drug International Standards Organization Import Trade Auxiliary Communications System Device Listing Number Mission Accomplishment and Regulatory Compliance Services Manufacturer Identification code New Drug Application National Drug Code National Formulary Operational and Administrative System for Import Support (FDA) Office of Regulatory Affairs (FDA) Over The Counter Product Development Protocol number Pre-Launch Activities Importation Request Private Label Distributor Premarket Approval number Premarket Notification number
- 4 -
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- thrift store reselling secrets you wish you knew 50
- here s the plan
- resale certificate
- wholesale distributor cover letter
- wholesale reseller account for internal use only
- 2011 crt 61 certificate of resale
- fda import requirements and best practices for
- starting a greenhouse business part 1 some basic
- selling jeans for profit pick4profit
- usa wholesalers list csv dlfiles24
Related searches
- financial best practices for nonprofits
- best practices for email communication
- salesforce best practices for sales
- best practices for nonprofit organizations
- best practices for finance departments
- best practices for teachers
- best practices for accountability
- best practices for reporting
- best practices for charitable foundations
- best practices for nonprofit
- best practices for relationship management
- best practices for email campaigns